WHO: Are You Ready for Human Genome Editing?

World Health Organization. Human Genome. Editing: Position Paper. Geneva: World Health Organization, 2021.

Nuffield Council of Bioethics. Genome Editing, An Ethical Review. London: Nuffield Council of Bioethics, 2016.

National Academies of Sciences , Engineering, and Medicine; National Academy of Medicine; National Academy of Sciences; Committee on Human Gene Editing: Scientific Medical , and Ethical Considerations . Human Genome Editing. Science, Ethics and Governance. Washington, DC: National Academies Press, 2017.

Nuffield Council of Bioethics. Genome Editing and Human. Reproduction: Social and Ethical Issues. London: Nuffield Council of Bioethics, 2018.

The Royal Society; National Academy of Sciences; National Academy of Medicine; International Commission on the Clinical Use of Human Germline Genome Editing. Heritable Human Genome Editing. Washington, DC: National Academies Press, 2020.

European Group on Ethics in Science and New Technologies. Ethics of Genome Editing. Luxembourg: Publications Office of the European Union, 2021.

Montoliu L , Merchant J , Hirsch F , et al. ARRIGE arrives: toward the responsible use of genome editing. CRISPR J, 2018; 1:128–129. DOI: 10.1089/crispr.2018.29012.mon.

Baylis F , Darnovsky M , Hasson K , et al. Human germ line and heritable genome editing: the global policy landscape. CRISPR J, 2020; 3:365–377. DOI: 10.1089/crispr.2020.0082.

Angrist M , Barrangou R , Baylis F , et al. Reactions to the National Academies/Royal Society report on heritable human genome editing. CRISPR J, 2020; 3:332–349. DOI: 10.1089/crispr.2020.29106.man.

Lu Y , Xue J , Deng T , et al. Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer. Nat Med, 2020; 26:732–740. DOI: 10.1038/s41591-020-0840-5.

Frangoul H , Altshuler D , Cappellini MD , et al. CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia. New Engl J Med, 2021; 384:252–260. DOI: 10.1056/NEJMoa2031054.

Gillmore JD , Gane E , Taubel J , et al. CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. New Engl J Med 2021 Jun 26 [Epub ahead of print]. DOI: 10.1056/NEJMoa210745..

Koblan LW , Erdos MR , Wilson C , et al. In vivo base editing rescues Hutchinson–Gilford progeria syndrome in mice. Nature, 2021; 589:608–614. DOI: 10.1038/s41586-020-03086-7.

Musunuru K , Chadwick AC , Mizoguchi T , et al. In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates. Nature, 2021; 593:429–434. DOI: 10.1038/s41586-021-03534-y.